FDA approves breakthrough drug to treat advanced pancreatic cancer
FDA sign at its headquarters in Washington, D.C. (Getty Images stock photo/JHVEPhoto) (WASHINGTON) -- The Food and Drug Administration approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer.The drug, called daraxonrasib, will be sold under the brand name Rasonque. The daily pill targets multiple forms of a protein called RAS, which is a main driver of tumor growth.This is a developing story. Please […]